Comparison of therapeutic effects of magnesium sulfate vs. Dexamethasone/metoclopramide on alleviating acute migraine headache

Journal of Emergency Medicine

Volumn 48, Issue 1, 2015, Pages 69-76

  Shahrami, Ali ^a   Assarzadegan, Farhad ^a   Hatamabadi, Hamid Reza ^a   Asgarzadeh, Morteza ^b   Sarehbandi, Baharak ^a   Asgarzadeh, Setareh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

dexamethasone; magnesium sulfate; metoclopramide; Migraine treatment

Indexed keywords

DEXAMETHASONE; MAGNESIUM SULFATE; METOCLOPRAMIDE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DRUG COMBINATION;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMERGENCY WARD; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NUMERIC RATING SCALE; PAIN SEVERITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT PLANNING; VERTIGO; VOMITING; ACUTE DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MIGRAINE DISORDERS; TIME; YOUNG ADULT;

ACUTE DISEASE; ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DOPAMINE D2 RECEPTOR ANTAGONISTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; METOCLOPRAMIDE; MIDDLE AGED; MIGRAINE DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84919871376     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2014.06.055     Document Type: Article

References (39)

1. T. Vos, A.D. Flaxman, and M. Naghavi Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 9859 2013 2163 2196
2. J.L. Natoli, A. Manack, and B. Dean Global prevalence of chronic migraine: a systematic review Cephalalgia 30 2010 599 609
3. J. Olesen, A. Gustavsson, and M. Svensson The economic cost of brain disorders in Europe Eur J Neurol 19 2012 155 162
4. M.D. Ferrari Headache: the changing migraine brain Lancet Neurol 12 2013 6 8
5. S.D. Silberstein Emerging target-based paradigms to prevent and treat migraine Clin Pharmacol Ther 93 2013 78 85
6. J.N. Goldstein, C.A. Camargo Jr., A.J. Pelletier, and J.A. Edlow Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses Cephalalgia 26 2006 684 690
7. J.U. Adelman, and R.D. Adelman Current options for the prevention and treatment of migraine Clin Ther 23 2001 772 788
8. S. Ashina, and R.K. Portenoy Intravenous treatment of migraine Tech Reg Anesth Pain Manag 16 2012 25 29
9. B.W. Friedman, P. Greenwald, and T.C. Bania Randomized trial of IV dexamethasone for acute migraine in the emergency department Neurology 69 2007 2038 2044
10. M. Chang, and A.M. Rapoport Acute treatment of migraine headache Techn Reg Anesth Pain Manag 13 2009 9 15
11. S. Demirkaya, O. Vural, and B. Dora Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks Headache 41 2001 171 177
12. D. Donaldson, R. Sundermann, R. Jackson, and A. Bastani Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial Am J Emerg Med 26 2008 124 130
13. B.W. Friedman, L. Mulvey, and D. Esses Metoclopramide for acute migraine: a dose-finding randomized clinical trial Ann Emerg Med 57 2011 475 482.e1
14. S. Ginder, B. Oatman, and M. Pollack A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches J Emerg Med 18 2000 311 315
15. A. Mauskop, B.T. Altura, R.Q. Cracco, and B.M. Altura Intravenous magnesium sulfate rapidly alleviates headaches of various types Headache 36 1996 154 160
16. A. Samaie, N. Asghari, R. Ghorbani, and J. Arda Blood magnesium levels in migraineurs within and between the headache attacks: a case control study Pan Afr Med J 11 2012 46
17. M. Talebi, D. Savadi-Oskouel, and M. Farhoudi Relation between serum magnesium level and migraine attacks Neurosciences (Riyadh) 16 2011 320 323
18. F. Facchinetti, G. Sances, P. Borella, A.R. Genazzani, and G. Nappi Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium Headache 31 1991 298 301
19. R.J. Vissers, and R. Purssell Iatrogenic magnesium overdose: two case reports J Emerg Med 14 1996 187 191
20. E.Y. Baden, and C.J. Hunter Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: a randomized, double-blind, placebo-controlled clinical trial CJEM 8 2006 393 400
21. P.H. Monzillo, P.H. Nemoto, A.R. Costa, and W.L. Sanvito [Acute treatment of migraine in emergency room: comparative study between dexametasone and haloperidol. Preliminary results] Arq Neuropsiquiatr 62 2B 2004 513 518
22. I. Colman, B.W. Friedman, and M.D. Brown Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence BMJ 336 7657 2008 1359 1361
23. A. Singh, H.J. Alter, and B. Zaia Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature Acad Emerg Med 15 2008 1223 1233
24. G.L. Ellis, J. Delaney, D.A. DeHart, and A. Owens The efficacy of metoclopramide in the treatment of migraine headache Ann Emerg Med 22 1993 191 195
25. D.S. Tek, D.S. McClellan, J.S. Olshaker, C.L. Allen, and D.C. Arthur A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department Ann Emerg Med 19 1990 1083 1087
26. th edn 2010 Mosby/Elsevier Philadelphia [electronic resource]
27. D.J. Capobianco, W.P. Cheshire, and J.K. Campbell An overview of the diagnosis and pharmacologic treatment of migraine Mayo Clin Proc 1996 1055
28. J. Edmeads Emergency management of headache Headache 1988 675
29. Y. Cete, B. Dora, C. Ertan, C. Ozdemir, and C. Oktay A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department Cephalalgia 25 2005 199 204
30. J. Corbo, D. Esses, P.E. Bijur, R. Iannaccone, and E.J. Gallagher Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache Ann Emerg Med 38 2001 621 627
31. K.H. Todd, K.G. Funk, J.P. Funk, and R. Bonacci Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
32. M. Coppola, D.M. Yealy, and R.A. Leibold Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache Ann Emerg Med 26 1995 541 546
33. I. Turkcuer, M. Serinken, and C. Eken Intravenous paracetamol versus dexketoprofen in acute migraine attack in the emergency department: a randomised clinical trial Emerg Med J 2014 182 185
34. J. Jones, S. Pack, and E. Chun Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache Am J Emerg Med 14 1996 262 269
35. C. Giuliano, R.D. Smalligan, G. Mitchon, and M. Chua Role of dexamethasone in the prevention of migraine recurrence in the acute care setting: a review Postgrad Med 124 2012 110 115
36. J.S. Jones, M.D. Brown, and M. Bermingham Efficacy of parenteral dexamethasone to prevent relapse after emergency department treatment of acute migraine Acad Emerg Med 10 2003 542 548
37. B.H. Rowe, I. Colman, M.L. Edmonds, S. Blitz, A. Walker, and S. Wiens Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache Headache 48 2008 333 340
38. M.E. Bigal, and R.B. Lipton When migraine progresses: transformed or chronic migraine Exp Rev Neurother 6 2006 297 306
39. B.G. Katzung, S.B. Masters, and A.J. Trevor Basic and Clinical Pharmacology 2003 McGraw-Hill Companies, Cap New York 269